Predictors at diagnosis for start of biologic disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis: a cohort study
Objectives To investigate the relation between patient characteristics at rheumatoid arthritis (RA) diagnosis and subsequent initiation of treatment with biologic disease-modifying antirheumatic drugs (bDMARDs) or targeted synthetic DMARDs (tsDMARDs).Design A retrospective cohort study.Setting and p...
Main Authors: | Carl Turesson, Giovanni Cagnotto, Mohaned Hameed, Sofia Exarchou, Ulf Bergström, Anna Eberhard, Ankita Sharma, Jon Thorkell Einarsson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/2/e076131.full |
Similar Items
-
Comorbidity in rheumatoid arthritis
by: Carl Turesson
Published: (2016-03-01) -
Protective effect of antirheumatic drugs on dementia in rheumatoid arthritis patients
by: Judge, AD, et al.
Published: (2017) -
Disease-modifying antirheumatic drugs in rheumatoid arthritis: current concepts.
by: Emery, P, et al.
Published: (1994) -
Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
by: Anne Mirjam Kerola, et al.
Published: (2021-05-01) -
Genetic Polymorphisms Associated with Rheumatoid Arthritis Development and Antirheumatic Therapy Response
by: Dmitry S. Mikhaylenko, et al.
Published: (2020-07-01)